[6] It is important to emphasize that when MB is used for these novel indications, it is being prescribed off-label on the basis of theoretical or preliminary evidence, and robust clinical trial data are still limited
One possible therapeutic mechanism was observed in experimental mice that exhibited augmented SOD, GSH, and CAT levels, and decreased MDA levels after AMP treatment
Recently, the FDA-approved ALK inhibitor ceritinib has been identified as a multikinase inhibitor targeting IGF-IR/InsR, FAK, and RSK1/2 as well [203]
In: Machlin L, ed
This condition, characterized by dark patches on the skin, occurs when melanin is produced in excess
And yet the stomach functions for decades without problems